AVITA Medical Reaffirms RECELL System Reduces Burn Patient LOS By 36%; More Discharged Home Vs. STSG

Author: Benzinga Newsdesk | September 04, 2025 06:51am

• Analysis of U.S. national burn registry data demonstrates 36% shorter hospital stays in adults with deep second-degree burns treated with RECELL versus traditional skin grafting
   
• More than $42,000 per patient cost savings, together with improved patient throughput, support operational and economic value
   
• Presented at the 2025 European Burn Association Congress in Berlin, Germany
   

VALENCIA, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) --  AVITA Medical, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today reaffirmed real-world data from the U.S. national burn registry demonstrating that the use of the RECELL® System significantly reduces hospital length of stay (LOS) by an average of 36% compared to traditional split thickness skin grafts (STSG) in adult patients with deep partial thickness (second degree) burns affecting up to 30% total body surface area. A greater proportion of RECELL-treated patients were discharged directly home, indicating improved recovery trajectories.

Posted In: RCEL